Annemasse, France

Santa Giovannoni

This inventor holds 1 USPTO granted patent. Top assignee: Novimmune Sa. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Santa Giovannoni. Retrieved from https://idiyas.com/inventor/santa-giovannoni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Santa Giovannoni: Innovator in Anti-TLR4 Antibodies

Introduction

Santa Giovannoni is a notable inventor based in Annemasse, France. He has made significant contributions to the field of immunology, particularly through his work on antibodies that target Toll-like Receptor 4 (TLR-4). His innovative approach has the potential to impact therapeutic methods and transplant medicine.

Latest Patents

Giovannoni holds a patent for "Anti-TLR4 antibodies and methods of use thereof." This invention relates to antibodies that specifically bind to TLR-4. The methods associated with these antibodies are aimed at preventing transplant rejection and prolonging the survival of transplanted biological material. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Santa Giovannoni is associated with Novimmune SA, a company that focuses on developing innovative therapeutic solutions. His work at Novimmune has allowed him to explore the therapeutic applications of anti-TLR4 antibodies, contributing to advancements in the field.

Collaborations

Giovannoni collaborates with esteemed colleagues, including Marie Kosco-Vilbois and Katrien De Graaf. These partnerships enhance the research and development efforts within his field, fostering innovation and progress.

Conclusion

Santa Giovannoni's work on anti-TLR4 antibodies represents a significant advancement in immunology and transplant medicine. His contributions through patents and collaborations continue to pave the way for future innovations in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…